• 1
    Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001; 1: 22231.
  • 2
    Jonkers J, Berns A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochem Biophys Acta 1996; 1287: 2957.
  • 3
    Mikkers H, Berns A. Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res 2003; 88: 5399.
  • 4
    Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy JD Jr, Jenkins NA, Copeland NG. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet 1999; 23: 34853.
  • 5
    Suzuki T, Shen H, Akagi K, Morse HC III, Malley JD, Naiman DQ, Jenkins NA, Copeland NG. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002; 32: 16674.
  • 6
    Devon RS, Porteous DJ, Brookes AJ. Splinkerettes-improved vectorettes for greater efficiency in PCR walking. Nucl Acids Res 1995; 23: 16445.
  • 7
    Mikkers H, Allen J, Knipscheer P, Romeyn L, Hart A, Vink E, Berns A. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 2002; 32: 1539.
  • 8
    Copeland NG, Jenkins NA. Myeloid leukemia: disease genes and mouse models. In: HiaiH, HinoO (eds). Animal Models of Cancer Predisposition Syndromes. Karger, Basel 1999; 5363.
  • 9
    Jenkins NA, Copeland NG, Taylor BA, Bedigian HG, Lee BK. Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice. J Virol 1982; 42: 37988.
  • 10
    Turcotte K, Gauthier S, Mitsos LM, Shustik C, Copeland NG, Jenkins NA, Fournet JC, Jolicoeur P, Gros P. Genetic control of myeloproliferation in BXH-2 mice. Blood 2004; 103: 234350.
  • 11
    Nakamura T, Largaespada DA, Shaughnessy Jr JD, Jenkins NA, Copeland NG. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat Genet 1996; 12: 14953.
  • 12
    Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 371425.
  • 13
    Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 2001; 20: 35061.
  • 14
    Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7; 11 (p15;p15)) in human myeloid leukaemia. Nat Genet 1996; 12: 1548.
  • 15
    Borrow J, Shearman AM, Stanton VP Jr, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE. The t (7; 11 (p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 1996; 12: 15967.
  • 16
    Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 5338.
  • 17
    Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 1991; 65: 75363.
  • 18
    Van Lohuzen M, Verbeek S, Scheijen B, Wientjens E, Van Der Gulden H, Berns A. Identification of cooperating oncogenes in Eµ-myc transgenic mice by provirus tagging. Cell 1991; 65: 73752.
  • 19
    Van Der Lugt NM, Domen J, Verhoeven E, Linders K, Vander Gulden H, Allen J, Berns A. Proviral tagging in Eµ-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J 1995; 14: 253644.
  • 20
    Verbeek S, Van Lohuizen M, Van Der Valk M, Domen J, Kraal G, Berns A. Mice bearing the Eµ-myc and Eµ-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol Cell Biol 1991; 11: 11769.
  • 21
    Allen JD, Verhoeven E, Domen J, Van Der Valk M, Berns A. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 1997; 15: 113341.
  • 22
    Saris CJM, Domen J, Berns A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J 1991; 10: 65564.
  • 23
    Van Der Lugt NM, Alkema M, Berns A, Deschamps J. The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. Mech Dev 1996; 58: 15364.
  • 24
    Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 25560.
  • 25
    Mikkers H, Allen J, Berns A. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EµMyc transgenic mice. Oncogene 2002; 21: 655966.
  • 26
    Bain G, Engel I, Maandag ECR, Te Riele HPJ, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 1997; 17: 478291.
  • 27
    Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M, Kurosawa T, Ochi T, Greene MI, Tsujimoto Y. Moloney murine leukemia virus infection accelerates lymphomagenesis in Eµ-bcl-2 transgenic mice. Oncogene 1995; 11: 172936.
  • 28
    Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, Russell R, DePinho RA, Lenz J, Van Lohuizen M. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 2002; 32: 1605.
  • 29
    Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M, Clurman BE. Identification of p27 complementing oncogenes by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci USA 2002; 99: 112938.
  • 30
    Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994; 372: 1439.
  • 31
    Goldman JM, Melo JV. Chronic myeloid leukemia-advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 145164.
  • 32
    Greaves MF, Wiemels J. Origins of chromosome translocation in childhood leukaemia. Nat Rev Cancer 2003; 3: 111.
  • 33
    Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves MF. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997; 94: 139504.
  • 34
    Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 1999; 94: 105762.
  • 35
    Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, Smith MT, Zhang L, Feusner J, Wiencke J, Pritchard-Jones K, Kempski H, Greaves M. In utero origin of t(8; 21) AML1–ETO translocation in childhood acute myeloid leukemia. Blood 2002; 99: 38015.
  • 36
    Look AT. Oncogenic transcription factors in human acute leukemias. Science 1997; 278: 105964.
  • 37
    Iwasaki M, Kuwata T, Yamazaki Y, Jenkins NA, Copeland NG, Osato M, Ito Y, Kroon E, Sauvageau G, Nakamura T. Identification of cooperative genes for NUP98-HOXA9 using a mouse model. Blood 2005.
  • 38
    Moloney JB. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Institute 1960; 24: 93351.
  • 39
    Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, Van Deursen JM. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol 1999; 19: 76476.
  • 40
    Xiu Y, Nakamura K, Abe M, Li N, Wen XS, Jiang Y, Zhang D, Tsurui H, Matsuoka S, Hamano Y, Fujii H, Ono M, Takai T, Shimokawa T, Ra C, Shirai T, Hirose S. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol 2002; 169: 43406.
  • 41
    Callanan MB, Le Baccon P, Mossuz P, Duley S, Bastard C, Hamoudi R, Dyer MJ, Klobeck G, Rimokh R, Sotto JJ, Leroux D. The IgG Fc receptor FcγRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Proc Natl Acad Sci USA 2000; 97: 30914.
  • 42
    Chen W, Palanisamy N, Schmidt H, Teruya-Feldstein J, Jhanwar SC, Zelenetz AD, Houldsworth J, Chaganti RSK. Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas. Oncogene 2001; 20: 768693.
  • 43
    Facchetti F, Cella M, Festa S, Fremont DH, Colonna M. An unusual Fc receptor-related protein expressed in human centroblasts. Proc Natl Acad Sci USA 2002; 99: 377681.
  • 44
    Davis RS, Li H, Chen CC, Wang YH, Cooper MD, Burrows PD. Definition of an Fc receptor-related gene (FcRX) expressed in human and mouse B cells. Int Immunol 2002; 14: 107583.
  • 45
    Milisav I. Dynein and dynein-related genes. Cell Motil Cytoskeleton 1998; 39: 26172.
  • 46
    Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3: 28796.
  • 47
    Puthalakath H, Villunger A, O'Reilly LA, King SM, Strasser A. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex activated by anoikis. Science 2001; 293: 182932.
  • 48
    Boylan K, Serr M, Hays T. A molecular genetic analysis of the interaction between the cytoplasmic Dynein intermediate chain and the Glued (Dynactin) complex. Mol Biol Cell 2000; 11: 3791803.
  • 49
    King SJ, Schroer TA. Dynactin increases the processivity of the cytoplasmic dynein motor. Nat Cell Biol 2000; 2: 204.
  • 50
    Kandil E, Noguchi M, Ishibashi T, Kasahara M. Structural and phylogenetic analysis of the MHC class I-like Fc receptor gene. J Immunol 1995; 154: 590718.
  • 51
    Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 10414.
  • 52
    Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, Owens J, Eckhaus M, Bodine D, Liu PP. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisoposes mice for acute myelomonocytic leukaemia. Nat Genet 1999; 23: 1446.
  • 53
    Castilla LH, Perrat P, Martinez NJ, Landrette SF, Keys R, Oikemus S, Flanegam J, Heilman S, Garrett L, Dutra A, Anderson S, Pihan GA, Wolff L, Liu PP. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc Natl Acad Sci USA 2004; 101: 49249.
  • 54
    Ott DE, Keller J, Sill K, Rein A. Phenotypes of murine leukemia virus-induced tumors: influence of 3′ viral coding sequences. J Virol 1992; 66: 610716.
  • 55
    Wolff L, Koller R, Davidson W. Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias. J Virol 1991; 65: 360716.
  • 56
    Nakamura T, Jenkins NA, Copeland NG. Identification of a new family of Pbx-related homeobox genes. Oncogene 1996; 13: 223542.
  • 57
    Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, De Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 4159.
  • 58
    Kohn DB, Sadelain M, Gloriose JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 2003; 3: 47788.
  • 59
    Royer-Pokora B, Loos U, Ludwig W-D. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11; 14 (p13;q11)). Oncogene 1991; 6: 188793.
  • 60
    Berns A. Good news for gene therapy. N Engl J Med 2004; 350: 167980.
  • 61
    Ben-David L, Aberdam D, Sachs L, Blatt C. A deletion and a rearrangement distinguish between the intracisternal A-particle of Hox-2.4 and that of interleukin-3 in the same leukemic cells. Virology 1991; 182: 3827.
  • 62
    Horie K, Kuroiwa A, Ikawa M, Okabe M, Kondoh G, Matsuda Y, Takeda J. Efficient chromosomal transposition of a Tc1/mariner-like transposon Sleeping Beauty in mice. Proc Natl Acad Sci USA 2001; 98: 91916.
  • 63
    Dupuy AJ, Clark K, Carlson CM, Fritz S, Davidson AE, Markley KM, Finley K, Fletcher CF, Ekker SC, Hackett PB, Horn S, Largaespada DA. Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci USA 2002; 99: 44959.
  • 64
    Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG, Hirokawa K, Nakamura T. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 2001; 29: 85663.